Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

EMERGENT BIOSOLUTIONS INC. Stock-Based Compensation

EMERGENT BIOSOLUTIONS INC. (EBS) reported Stock-Based Compensation of $8.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-06

  • EMERGENT BIOSOLUTIONS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $6.90M, a 50.00% increase year-over-year.
  • EMERGENT BIOSOLUTIONS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.90M, a 26.67% increase year-over-year.
  • EMERGENT BIOSOLUTIONS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $5.30M, a 23.26% increase year-over-year.
  • EMERGENT BIOSOLUTIONS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $4.80M, a 108.70% increase year-over-year.
  • EMERGENT BIOSOLUTIONS INC. share-based payment arrangement, noncash expense for fiscal 2025 was $16.20M, a 10.00% decline from fiscal 2024.
  • EMERGENT BIOSOLUTIONS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $18.00M, a 22.08% decline from fiscal 2023.
  • EMERGENT BIOSOLUTIONS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $23.10M, a 48.78% decline from fiscal 2022.
  • EMERGENT BIOSOLUTIONS INC. share-based payment arrangement, noncash expense for fiscal 2022 was $45.10M, a 6.37% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-30$6.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$8.80M
10-Q · filed 2026-08-06
$14.10M
derived: sum of 3 quarters · filed 2026-08-06
$18.90M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$1.90M
10-Q · filed 2026-05-01
$7.20M
derived: sum of 2 quarters · filed 2026-05-01
$12.00M
derived: sum of 3 quarters · filed 2026-05-01
$16.60M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$5.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$10.10M
derived: sum of 2 quarters · filed 2026-02-27
$14.70M
derived: sum of 3 quarters · filed 2026-08-06
$16.20M
10-K · filed 2026-02-27
2025-09-30$4.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$9.40M
derived: sum of 2 quarters · filed 2026-08-06
$10.90M
10-Q · filed 2025-10-30
$15.20M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$4.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$6.10M
10-Q · filed 2026-08-06
$10.40M
derived: sum of 3 quarters · filed 2026-08-06
$12.70M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.50M
10-Q · filed 2026-05-01
$5.80M
derived: sum of 2 quarters · filed 2026-05-01
$8.10M
derived: sum of 3 quarters · filed 2026-05-01
$13.60M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31$4.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$6.60M
derived: sum of 2 quarters · filed 2026-02-27
$12.10M
derived: sum of 3 quarters · filed 2026-02-27
$18.00M
10-K · filed 2026-02-27
2024-09-30$2.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$7.80M
derived: sum of 2 quarters · filed 2025-10-30
$13.70M
10-Q · filed 2025-10-30
$17.70M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$5.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$11.40M
10-Q · filed 2025-08-07
$15.40M
derived: sum of 3 quarters · filed 2026-02-27
$19.40M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$5.90M
10-Q · filed 2025-05-08
$9.90M
derived: sum of 2 quarters · filed 2026-02-27
$13.90M
derived: sum of 3 quarters · filed 2026-02-27
$22.20M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$8.00M
derived: sum of 2 quarters · filed 2026-02-27
$16.30M
derived: sum of 3 quarters · filed 2026-02-27
$23.10M
10-K · filed 2026-02-27
2023-09-30$4.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$12.30M
derived: sum of 2 quarters · filed 2024-11-07
$19.10M
10-Q · filed 2024-11-07
$30.80M
derived: sum of 4 quarters · filed 2025-03-04
2023-06-30$8.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$15.10M
10-Q · filed 2024-08-07
$26.80M
derived: sum of 3 quarters · filed 2025-03-04
$38.00M
derived: sum of 4 quarters · filed 2025-03-04
2023-03-31$6.80M
10-Q · filed 2024-05-02
$18.50M
derived: sum of 2 quarters · filed 2025-03-04
$29.70M
derived: sum of 3 quarters · filed 2025-03-04
$42.00M
derived: sum of 4 quarters · filed 2025-03-04
2022-12-31$11.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
$22.90M
derived: sum of 2 quarters · filed 2025-03-04
$35.20M
derived: sum of 3 quarters · filed 2025-03-04
$45.10M
10-K · filed 2025-03-04
2022-09-30$11.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11
$23.50M
derived: sum of 2 quarters · filed 2023-12-11
$33.40M
10-Q · filed 2023-12-11
$43.50M
derived: sum of 4 quarters · filed 2024-03-08
2022-06-30$12.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$22.20M
10-Q · filed 2023-08-09
$32.30M
derived: sum of 3 quarters · filed 2024-03-08
$42.70M
derived: sum of 4 quarters · filed 2024-03-08
2022-03-31$9.90M
10-Q · filed 2023-05-10
$20.00M
derived: sum of 2 quarters · filed 2024-03-08
$30.40M
derived: sum of 3 quarters · filed 2024-03-08
$41.80M
derived: sum of 4 quarters · filed 2024-03-08
2021-12-31$10.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
$20.50M
derived: sum of 2 quarters · filed 2024-03-08
$31.90M
derived: sum of 3 quarters · filed 2024-03-08
$42.40M
10-K · filed 2024-03-08
2021-09-30$10.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$21.80M
derived: sum of 2 quarters · filed 2022-11-09
$32.30M
10-Q · filed 2022-11-09
$43.10M
derived: sum of 4 quarters · filed 2023-12-11
2021-06-30$11.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$21.90M
10-Q · filed 2022-08-02
$32.70M
derived: sum of 3 quarters · filed 2023-12-11
$42.70M
derived: sum of 4 quarters · filed 2023-12-11
2021-03-31$10.50M
10-Q · filed 2022-04-29
$21.30M
derived: sum of 2 quarters · filed 2023-12-11
$31.30M
derived: sum of 3 quarters · filed 2023-12-11
$55.70M
derived: sum of 4 quarters · filed 2023-12-11
2020-12-31$10.80M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11
$20.80M
derived: sum of 2 quarters · filed 2023-12-11
$45.20M
derived: sum of 3 quarters · filed 2023-12-11
$51.80M
10-K/A · filed 2023-12-11
$51.00M
10-K · filed 2021-02-19
2020-09-30$10.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$34.40M
derived: sum of 2 quarters · filed 2021-11-05
$41.00M
10-Q · filed 2021-11-05
$46.70M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$24.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$31.00M
10-Q · filed 2021-07-30
$36.70M
derived: sum of 3 quarters · filed 2022-02-25
$42.80M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$6.60M
10-Q · filed 2021-04-30
$12.30M
derived: sum of 2 quarters · filed 2022-02-25
$18.40M
derived: sum of 3 quarters · filed 2022-02-25
$26.50M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$5.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$11.80M
derived: sum of 2 quarters · filed 2022-02-25
$19.90M
derived: sum of 3 quarters · filed 2022-02-25
$26.70M
10-K · filed 2022-02-25
2019-09-30$6.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$14.20M
derived: sum of 2 quarters · filed 2020-11-06
$21.00M
10-Q · filed 2020-11-06
$27.50M
derived: sum of 4 quarters · filed 2021-02-19
2019-06-30$8.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$14.90M
10-Q · filed 2020-07-31
$21.40M
derived: sum of 3 quarters · filed 2021-02-19
$26.40M
derived: sum of 4 quarters · filed 2021-02-19
2019-03-31$6.80M
10-Q · filed 2020-05-01
$13.30M
derived: sum of 2 quarters · filed 2021-02-19
$18.30M
derived: sum of 3 quarters · filed 2021-02-19
$22.70M
derived: sum of 4 quarters · filed 2021-02-19
2018-12-31$6.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$11.50M
derived: sum of 2 quarters · filed 2021-02-19
$15.90M
derived: sum of 3 quarters · filed 2021-02-19
$23.20M
10-K · filed 2021-02-19
2018-09-30$5.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$9.40M
derived: sum of 2 quarters · filed 2019-11-07
$16.70M
10-Q · filed 2019-11-07
$16.66M
10-Q · filed 2018-11-02
$20.09M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$4.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$11.70M
10-Q · filed 2019-08-02
$11.71M
10-Q · filed 2018-08-03
$15.10M
derived: sum of 3 quarters · filed 2020-02-25
$18.88M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$7.30M
10-Q · filed 2019-05-08
$7.25M
10-Q · filed 2018-05-04
$10.70M
derived: sum of 2 quarters · filed 2020-02-25
$14.48M
derived: sum of 3 quarters · filed 2020-02-25
$18.22M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$3.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$7.18M
derived: sum of 2 quarters · filed 2020-02-25
$10.92M
derived: sum of 3 quarters · filed 2020-02-25
$15.20M
10-K · filed 2020-02-25
$15.21M
10-K · filed 2018-02-23
2017-09-30$3.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$7.52M
derived: sum of 2 quarters · filed 2018-11-02
$11.80M
10-Q · filed 2018-11-02
$15.78M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$3.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
$8.02M
10-Q · filed 2018-08-03
$11.99M
derived: sum of 3 quarters · filed 2019-02-22
$16.57M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31$4.28M
10-Q · filed 2018-05-04
$8.26M
derived: sum of 2 quarters · filed 2019-02-22
$12.84M
derived: sum of 3 quarters · filed 2019-02-22
$17.59M
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31$3.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$8.55M
derived: sum of 2 quarters · filed 2019-02-22
$13.30M
derived: sum of 3 quarters · filed 2019-02-22
$18.50M
10-K · filed 2019-02-22
$18.48M
10-K · filed 2017-02-28
2016-09-30$4.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$9.33M
derived: sum of 2 quarters · filed 2017-11-03
$14.53M
10-Q · filed 2017-11-03
$18.57M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$4.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$9.95M
10-Q · filed 2017-08-04
$13.99M
derived: sum of 3 quarters · filed 2018-02-23
$18.00M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$5.20M
10-Q · filed 2017-05-05
$9.24M
derived: sum of 2 quarters · filed 2018-02-23
$13.26M
derived: sum of 3 quarters · filed 2018-02-23
$17.25M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$4.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$8.06M
derived: sum of 2 quarters · filed 2018-02-23
$12.05M
derived: sum of 3 quarters · filed 2018-02-23
$15.85M
10-K · filed 2018-02-23
2015-09-30$4.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$8.00M
derived: sum of 2 quarters · filed 2016-11-09
$11.80M
10-Q · filed 2016-11-09
$15.18M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$3.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$7.79M
10-Q · filed 2016-08-05
$11.16M
derived: sum of 3 quarters · filed 2017-02-28
$14.60M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$3.80M
10-Q · filed 2016-05-06
$7.17M
derived: sum of 2 quarters · filed 2017-02-28
$10.61M
derived: sum of 3 quarters · filed 2017-02-28
$13.98M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$3.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$6.81M
derived: sum of 2 quarters · filed 2017-02-28
$10.18M
derived: sum of 3 quarters · filed 2017-02-28
$12.83M
10-K · filed 2017-02-28
2014-09-30$3.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$6.80M
derived: sum of 2 quarters · filed 2015-11-06
$9.45M
10-Q · filed 2015-11-06
$12.23M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$3.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$6.01M
10-Q · filed 2015-08-06
$8.79M
derived: sum of 3 quarters · filed 2016-02-29
$11.54M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$2.65M
10-Q · filed 2015-05-08
$5.43M
derived: sum of 2 quarters · filed 2016-02-29
$8.17M
derived: sum of 3 quarters · filed 2016-02-29
$10.91M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$2.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$5.52M
derived: sum of 2 quarters · filed 2016-02-29
$8.26M
derived: sum of 3 quarters · filed 2016-02-29
$11.24M
10-K · filed 2016-02-29
2013-09-30$2.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$5.48M
derived: sum of 2 quarters · filed 2014-11-10
$8.46M
10-Q · filed 2014-11-10
$11.16M
derived: sum of 4 quarters · filed 2015-03-09
2013-06-30$2.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$5.72M
10-Q · filed 2014-08-08
$8.42M
derived: sum of 3 quarters · filed 2015-03-09
$11.41M
derived: sum of 4 quarters · filed 2015-03-09
2013-03-31$2.98M
10-Q · filed 2014-05-12
$5.67M
derived: sum of 2 quarters · filed 2015-03-09
$8.67M
derived: sum of 3 quarters · filed 2015-03-09
$11.38M
derived: sum of 4 quarters · filed 2015-03-09
2012-12-31$2.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
$5.69M
derived: sum of 2 quarters · filed 2015-03-09
$8.40M
derived: sum of 3 quarters · filed 2015-03-09
$11.12M
10-K · filed 2015-03-09
2012-09-30$2.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$5.71M
derived: sum of 2 quarters · filed 2013-11-08
$8.42M
10-Q · filed 2013-11-08
$11.24M
derived: sum of 4 quarters · filed 2014-03-10
2012-06-30$2.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
$5.42M
10-Q · filed 2013-08-06
$8.25M
derived: sum of 3 quarters · filed 2014-03-10
$11.01M
derived: sum of 4 quarters · filed 2014-03-10
2012-03-31$2.71M
10-Q · filed 2013-05-03
$5.54M
derived: sum of 2 quarters · filed 2014-03-10
$8.30M
derived: sum of 3 quarters · filed 2014-03-10
$11.01M
derived: sum of 4 quarters · filed 2014-03-10
2011-12-31$2.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10
$5.59M
derived: sum of 2 quarters · filed 2014-03-10
$8.30M
derived: sum of 3 quarters · filed 2014-03-10
$10.74M
10-K · filed 2014-03-10
2011-09-30$2.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
$5.47M
derived: sum of 2 quarters · filed 2012-11-01
$7.91M
10-Q · filed 2012-11-01
$9.77M
derived: sum of 4 quarters · filed 2013-03-08
2011-06-30$2.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
$5.15M
10-Q · filed 2012-08-03
$7.01M
derived: sum of 3 quarters · filed 2013-03-08
$8.85M
derived: sum of 4 quarters · filed 2013-03-08
2011-03-31$2.44M
10-Q · filed 2012-05-04
$4.30M
derived: sum of 2 quarters · filed 2013-03-08
$6.14M
derived: sum of 3 quarters · filed 2013-03-08
2010-12-31$1.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08
$3.70M
derived: sum of 2 quarters · filed 2013-03-08
$7.06M
10-K · filed 2013-03-08
2010-09-30$1.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$5.21M
10-Q · filed 2011-11-04
2010-06-30$3.36M
10-Q · filed 2011-08-05
2009-12-31$5.01M
10-K · filed 2012-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45